uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
STREET - Somatostatin Treatment Experience Trial
Skane Univ Hosp, Dept Surg, Lund, Sweden..
IPSEN, Stockholm, Sweden..
IPSEN, Stockholm, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Endocrin Oncology.
2017 (English)In: Neuroendocrinology, ISSN 0028-3835, E-ISSN 1423-0194, Vol. 105, p. 191-191Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
KARGER , 2017. Vol. 105, p. 191-191
Keywords [en]
somatostatin analogs, octreotide, lanreotide, quality of life, injection
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:uu:diva-346590ISI: 000413957900192OAI: oai:DiVA.org:uu-346590DiVA, id: diva2:1191812
Conference
14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, MAR 08-10, 2017, Barcelona, SPAIN
Available from: 2018-03-20 Created: 2018-03-20 Last updated: 2018-03-20Bibliographically approved

Open Access in DiVA

No full text in DiVA

By organisation
Endocrin Oncology
In the same journal
Neuroendocrinology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 295 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf